Macrocyclic mcl-1 inhibitors and methods of use
US-2025313572-A1 · Oct 9, 2025 · US
Wendt Michael is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wendt Michael |
| Total patents | 16 |
| First publication | Oct 22, 2015 |
| Latest publication | Oct 9, 2025 |
Publications ranked by popularity score, then publication date.
US-2025313572-A1 · Oct 9, 2025 · US
US-2024311684-A1 · Sep 19, 2024 · US
US-2024228509-A1 · Jul 11, 2024 · US
US-2023399340-A1 · Dec 14, 2023 · US
US-2022259226-A1 · Aug 18, 2022 · US
US-2021403467-A1 · Dec 30, 2021 · US
US-2021292339-A1 · Sep 23, 2021 · US
US-2020331907-A1 · Oct 22, 2020 · US
US-2020255451-A1 · Aug 13, 2020 · US
US-2020239494-A1 · Jul 30, 2020 · US
Latest publications not already listed above.
US-10192051-B2 · Jan 29, 2019 · US
US-2018354952-A1 · Dec 13, 2018 · US
US-10081628-B2 · Sep 25, 2018 · US
US-2017008891-A1 · Jan 12, 2017 · US
US-2016373476-A1 · Dec 22, 2016 · US
US-2015299197-A1 · Oct 22, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Abbvie Inc | 13 |
| Abbvie Deutschland | 7 |
| Accenture Global Services Ltd | 2 |
| Siemens Healthineers Ag | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 13 |
| A61K45/06 | 10 |
| C07D495/16 | 7 |
| A61K31/519 | 7 |
| C07D519/00 | 7 |